Inhibition of Janus kinase/signal transducer and activator of transcription (JAK/STAT) signalling pathway in rheumatoid synovial fibroblasts using small molecule compounds. 2013

K Migita, and Y Izumi, and T Torigoshi, and K Satomura, and M Izumi, and Y Nishino, and Y Jiuchi, and M Nakamura, and H Kozuru, and F Nonaka, and K Eguchi, and A Kawakami, and S Motokawa
Department of Rheumatology and Clinical Research Center, Nagasaki Medical Center, Omura, Nagasaki, Japan.

Janus kinase (JAK) inhibitors have been developed as anti-inflammatory agents and have demonstrated clinical efficacy in rheumatoid arthritis (RA). We investigated if JAK-3-selective inhibition alone could disrupt cytokine signalling in rheumatoid synovial fibroblasts. In-vitro studies were performed using synovial fibroblasts isolated from patients with RA. Levels of activated JAK and signal transducer and activator of transcription (STAT) proteins were detected by immunoblot analysis. Target-gene expression levels were measured by reverse transcription-polymerase chain reaction (RT-PCR) or real-time PCR. The JAK inhibitors CP-690,550 and INCB028050 both suppressed activation of JAK-1/-2/-3 and downstream STAT-1/-3/-5, as well as the expression levels of target proinflammatory genes (MCP-I, SAA1/2) in oncostatin-M (OSM)-stimulated rheumatoid synovial fibroblasts. In contrast, the JAK-3-selective inhibitor, PF-956980, suppressed STAT-1/-5 activation but did not affect STAT-3 activation in OSM-stimulated rheumatoid synovial fibroblasts. In addition, PF-956980 significantly suppressed MCP-1 gene expression, but did not block SAA1/2 gene expression in OSM-stimulated rheumatoid synovial fibroblasts. These data suggest that JAK-3-selective inhibition alone is insufficient to control STAT-3-dependent signalling in rheumatoid synovial fibroblasts, and inhibition of JAKs, including JAK-1/-2, is needed to control the proinflammatory cascade in RA.

UI MeSH Term Description Entries
D010880 Piperidines A family of hexahydropyridines.
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D011758 Pyrroles Azoles of one NITROGEN and two double bonds that have aromatic chemical properties. Pyrrole
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D013582 Synovial Fluid The clear, viscous fluid secreted by the SYNOVIAL MEMBRANE. It contains mucin, albumin, fat, and mineral salts and serves to lubricate joints. Synovia,Fluid, Synovial,Fluids, Synovial,Synovial Fluids
D013583 Synovial Membrane The inner membrane of a joint capsule surrounding a freely movable joint. It is loosely attached to the external fibrous capsule and secretes SYNOVIAL FLUID. Synovium,Membrana Synovialis Capsulae Articularis,Membrane, Synovial,Membranes, Synovial,Synovial Membranes
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D047428 Protein Kinase Inhibitors Agents that inhibit PROTEIN KINASES. Protein Kinase Inhibitor,Inhibitor, Protein Kinase,Inhibitors, Protein Kinase,Kinase Inhibitor, Protein,Kinase Inhibitors, Protein

Related Publications

K Migita, and Y Izumi, and T Torigoshi, and K Satomura, and M Izumi, and Y Nishino, and Y Jiuchi, and M Nakamura, and H Kozuru, and F Nonaka, and K Eguchi, and A Kawakami, and S Motokawa
May 2000, Molecular endocrinology (Baltimore, Md.),
K Migita, and Y Izumi, and T Torigoshi, and K Satomura, and M Izumi, and Y Nishino, and Y Jiuchi, and M Nakamura, and H Kozuru, and F Nonaka, and K Eguchi, and A Kawakami, and S Motokawa
November 2021, International journal of molecular sciences,
K Migita, and Y Izumi, and T Torigoshi, and K Satomura, and M Izumi, and Y Nishino, and Y Jiuchi, and M Nakamura, and H Kozuru, and F Nonaka, and K Eguchi, and A Kawakami, and S Motokawa
January 2009, BioFactors (Oxford, England),
K Migita, and Y Izumi, and T Torigoshi, and K Satomura, and M Izumi, and Y Nishino, and Y Jiuchi, and M Nakamura, and H Kozuru, and F Nonaka, and K Eguchi, and A Kawakami, and S Motokawa
December 2021, BMC research notes,
K Migita, and Y Izumi, and T Torigoshi, and K Satomura, and M Izumi, and Y Nishino, and Y Jiuchi, and M Nakamura, and H Kozuru, and F Nonaka, and K Eguchi, and A Kawakami, and S Motokawa
January 2013, Clinical and experimental rheumatology,
K Migita, and Y Izumi, and T Torigoshi, and K Satomura, and M Izumi, and Y Nishino, and Y Jiuchi, and M Nakamura, and H Kozuru, and F Nonaka, and K Eguchi, and A Kawakami, and S Motokawa
July 2024, Phytomedicine : international journal of phytotherapy and phytopharmacology,
K Migita, and Y Izumi, and T Torigoshi, and K Satomura, and M Izumi, and Y Nishino, and Y Jiuchi, and M Nakamura, and H Kozuru, and F Nonaka, and K Eguchi, and A Kawakami, and S Motokawa
March 2018, Reproduction, fertility, and development,
K Migita, and Y Izumi, and T Torigoshi, and K Satomura, and M Izumi, and Y Nishino, and Y Jiuchi, and M Nakamura, and H Kozuru, and F Nonaka, and K Eguchi, and A Kawakami, and S Motokawa
January 2012, Biological & pharmaceutical bulletin,
K Migita, and Y Izumi, and T Torigoshi, and K Satomura, and M Izumi, and Y Nishino, and Y Jiuchi, and M Nakamura, and H Kozuru, and F Nonaka, and K Eguchi, and A Kawakami, and S Motokawa
October 2022, Cryobiology,
K Migita, and Y Izumi, and T Torigoshi, and K Satomura, and M Izumi, and Y Nishino, and Y Jiuchi, and M Nakamura, and H Kozuru, and F Nonaka, and K Eguchi, and A Kawakami, and S Motokawa
December 2017, The Journal of biological chemistry,
Copied contents to your clipboard!